1. Medicine

Category Archives: Medicine

Chronic Pain Medication: Am I Addicted To My Pain Medicine? Columbia Pain Management – Video

Posted on by


Chronic Pain Medication: Am I Addicted To My Pain Medicine? Columbia Pain Management
https://plus.google.com/109269582495381653038/about (541) 716-6469 Am I Addicted To My Pain Medicine? Dr Rigert talks about how to tell if you #39;re addicted to...

By: Trey Rigert

See the original post here:

Chronic Pain Medication: Am I Addicted To My Pain Medicine? Columbia Pain Management - Video

Performance Medicine named official partner for Texas Rush

Posted on by

THE WOODLANDS St. Lukes Performance Medicine, a department of St. Lukes The Woodlands Hospital, has partnered with the Texas Rush Soccer Club to become its official sports medicine provider.

In addition, St. Lukes Performance Medicine will have a presence at select Texas Rush Soccer Club events to provide sports medicine, injury prevention, concussion screening and management and first-aid services by licensed athletic trainers. Complimentary athletic training evaluation clinics also are available for the clubs coaches and athletes.

St. Lukes Performance Medicine is a technologically and clinically advanced physical rehabilitation and human performance testing and training facility with specialization in sports medicine and sports performance training.

We are excited to facilitate this relationship with the Texas Rush Soccer Club through our stellar performance medicine offerings and quality healthcare system, said David Argueta, chief operating officer of SLWH. By providing a direct line of performance medicine services to this well-known sports club, St. Lukes is demonstrating our commitment to community outreach to encourage a healthier athletic and active lifestyle. In addition, our healthcare navigators can assist players and their family members with direct access to the CHI St. Lukes Healths network full spectrum of advanced family centered health care, guiding them through the physician referral and scheduling processes from pediatrics to geriatrics, emergency center to the birthing center, and diagnostics to surgery. We look forward to providing such partnerships and affiliations with other organizations who desire to achieve optimal performance through our training, injury prevention and wellness services.

St. Lukes Performance Medicine Department is located on the campus of SLWH in the Medical Arts Center Building III (MAC III) at 17450 St. Lukes Way, Suite 350. For more information, call 936-266-3130 or visit stlukesperformancemedicine.com.

Read more:

Performance Medicine named official partner for Texas Rush

Penn Medicine Researchers Present Findings on New Interventions for Treatment Resistant Hypertension, Atherosclerosis …

Posted on by

WASHINGTON, DC Penn Medicine experts presented research findings that could come to define new standards of cardiovascular care, including findings on the efficacy of novel interventions for treatment resistant hypertension and atherosclerosis, at the 2014 American College of Cardiology Scientific Session, ACC.14.

Late Breaking Clinical Trial Results

Saturday, March 29

Despite promising early phase research, the pivotal SYMPLICITY HTN-3 trial evaluating the use of Medtronic's renal denervation system in the U.S. in patients with treatment-resistant hypertension failed to meet its primary efficacy endpoint, researchers reported at 2014 American College of Cardiology meeting and published simultaneously in an online-first New England Journal of Medicine article.

The procedure involves inserting a catheter through an artery in the groin, which is threaded up to the renal artery, where a catheter using radio frequency energy is used to disrupt the renal nerves, thereby reducing a patients elevated blood pressure.

The trial randomized 535 treatment-resistant hypertension patients in 87 U.S. medical centers, including the Hospital of the University of Pennsylvania. Patients receiving the investigational treatment were compared with a sham-procedure control group (that received femoral artery puncture and renal angiogram) under conscious sedation, with all patients continuing to take their blood pressure medications. The primary efficacy endpoint was the change in office systolic blood pressure (upper blood pressure reading) at six months.

Researchers reported that while the trial did meet its safety endpoints and there were no signals that safety was a concern in the study, it did not demonstrate a significant reduction of systolic blood pressure six months after renal artery denervation versus sham control. Trials planning to enroll new patients with high blood pressure for treatment with the denervation device were suspended in January 2014 when the preliminary efficacy data was first released by the manufacturer. Patients already enrolled and treated in the trial are still in active follow-up.

The authors note that the based on positive results in previous phases of the study, that a placebo effect may have been present in the phase III trial by having an invasive procedure in the control group, which may have increased patient compliance with medication and diet. The concept has important therapeutic implications for future trial designs of antihypertensive (and other) medications, devices, and strategies.

These trial results are, in my mind, more a sign that we need to reconsider patient selection, patient and investigator/provider expectations, as well as improve our understanding of what basically happens during renal denervation, rather than shucking the process all together, said study co-author Raymond R. Townsend, MD , professor of Medicine and director of the Penn Hypertension Program. Several thousand people from around the world have already been treated, seemingly effectively, with this procedure when medication therapy failed. I believe its too early to say where/whether renal denervation fits into resistant hypertension care, but I dont think we are ready to give up on it at this time, and additional research is needed to acquire a more complete understanding of the procedure.

Sunday, March 28

Excerpt from:

Penn Medicine Researchers Present Findings on New Interventions for Treatment Resistant Hypertension, Atherosclerosis ...

PSTI to Present Poster on GvHD & Panel Discussion at BIRAX Regenerative Medicine Conference – Video

Posted on by


PSTI to Present Poster on GvHD Panel Discussion at BIRAX Regenerative Medicine Conference
HAIFA, Israel, March 25, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, toda...

By: CorporateProfile

Read the original:

PSTI to Present Poster on GvHD & Panel Discussion at BIRAX Regenerative Medicine Conference - Video

Martha Rodriguez M.D. Internal Medicine Geriatric Healthcare Boynton Beach – Video

Posted on by


Martha Rodriguez M.D. Internal Medicine Geriatric Healthcare Boynton Beach
Phone: (561) 364-8056 http://www.mmrhealthcare.com https://www.mmrhealthcare.com/appointments.php Internal Medicine, Geriatric Healthcare, Primary Care Marth...

By: Martha M. Rodriguez MD PA

View original post here:

Martha Rodriguez M.D. Internal Medicine Geriatric Healthcare Boynton Beach - Video


  1. Medicine